Markus Bosmann, MD
Associate Professor
Boston University School of Medicine
Dept of Medicine
Pulmonary, Allergy, Sleep & Critical Care Medicine

MD, Goethe University Frankfurt




Dr. Bosmann is an assistant professor at the Boston University School of Medicine. His research interests include pulmonary disorders and their connections to innate immunity, host-pathogen interactions, and inflammation.

Associate Professor
Boston University School of Medicine
Pathology & Laboratory Medicine


Member
Boston University
Pulmonary Center


Member
Boston University
Evans Center for Interdisciplinary Biomedical Research


Member
Boston University
Genome Science Institute


Graduate Faculty (Primary Mentor of Grad Students)
Boston University School of Medicine, Graduate Medical Sciences




Bacterial polyphosphates in sepsis
02/22/2021 - 01/31/2025 (PI)
NIH/National Institute of Allergy & Infectious Diseases
5R01AI153613-02

Role reversal of MAVS in bacterial sepsis
08/15/2018 - 06/30/2023 (PI)
NIH/National Heart, Lung, and Blood Institute
5R01HL141513-04

New genetic models for C5a receptors
07/01/2018 - 06/30/2023 (PI)
NIH/National Heart, Lung, and Blood Institute
5R01HL139641-04

Therapeutic effects of NAPc2 in SARS-CoV-2 infection of K18-hACE2 transgenic mice
03/15/2021 - 03/31/2022 (Multi-PI)
PI: Markus Bosmann, MD
ARCA Biopharma, Inc.


Anti-complement therapy: a drug target for COVID-19-induced inflammation and coagulation
03/01/2021 - 02/28/2022 (Key Person / Mentor)
PI: Saravanan Subramaniam, PhD
Aniara Diagnostica




Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Kenney DJ, O'Connell AK, Turcinovic J, Montanaro P, Hekman RM, Tamura T, Berneshawi AR, Cafiero TR, Al Abdullatif S, Blum B, Goldstein SI, Heller BL, Gertje HP, Bullitt E, Trachtenberg AJ, Chavez E, Nono ET, Morrison C, Tseng AE, Sheikh A, Kurnick S, Grosz K, Bosmann M, Ericsson M, Huber BR, Saeed M, Balazs AB, Francis KP, Klose A, Paragas N, Campbell JD, Connor JH, Emili A, Crossland NA, Ploss A, Douam F. Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection. Cell Rep. 2022 Apr 19; 39(3):110714.View Related Profiles. PMID: 35421379; PMCID: PMC8977517; DOI: 10.1016/j.celrep.2022.110714;
     
  2. Sharma A, Noon JB, Kontodimas K, Garo LP, Platten J, Quinton LJ, Urban JF, Reinhardt C, Bosmann M. IL-27 Enhances ?d T Cell-Mediated Innate Resistance to Primary Hookworm Infection in the Lungs. J Immunol. 2022 Apr 15; 208(8):2008-2018.View Related Profiles. PMID: 35354611
     
  3. Carossino M, Kenney D, O'Connell AK, Montanaro P, Tseng AE, Gertje HP, Grosz KA, Ericsson M, Huber BR, Kurnick SA, Subramaniam S, Kirkland TA, Walker JR, Francis KP, Klose AD, Paragas N, Bosmann M, Saeed M, Balasuriya UBR, Douam F, Crossland NA. Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression. Viruses. 2022 03 05; 14(3).View Related Profiles. PMID: 35336942; PMCID: PMC8955233; DOI: 10.3390/v14030535;
     
  4. Sanders NL, Martin IMC, Sharma A, Jones MR, Quinton LJ, Bosmann M, Mizgerd JP. Neutrophil Extracellular Traps as an Exacerbating Factor in Bacterial Pneumonia. Infect Immun. 2022 03 17; 90(3):e0049121.View Related Profiles. PMID: 35130455; PMCID: PMC8929384; DOI: 10.1128/iai.00491-21;
     
  5. Sharma A, Kontodimas K, Bosmann M. The MAVS Immune Recognition Pathway in Viral Infection and Sepsis. Antioxid Redox Signal. 2021 12; 35(16):1376-1392. PMID: 34348482; PMCID: PMC8817698; DOI: 10.1089/ars.2021.0167;
     
  6. Helmstädter J, Keppeler K, Aust F, Küster L, Frenis K, Filippou K, Vujacic-Mirski K, Tsohataridis S, Kalinovic S, Kröller-Schön S, Oelze M, Bosmann M, Münzel T, Daiber A, Steven S. GLP-1 Analog Liraglutide Improves Vascular Function in Polymicrobial Sepsis by Reduction of Oxidative Stress and Inflammation. Antioxidants (Basel). 2021 Jul 23; 10(8). PMID: 34439423; PMCID: PMC8388926; DOI: 10.3390/antiox10081175;
     
  7. Subramaniam S, Ruf W, Bosmann M. Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019. Br J Pharmacol. 2022 May; 179(10):2086-2099.View Related Profiles. PMID: 34235728; PMCID: PMC8794588; DOI: 10.1111/bph.15587;
     
  8. Sharma A, Kontodimas K, Bosmann M. Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19. Front Med (Lausanne). 2021; 8:648005. PMID: 34150793; PMCID: PMC8211875; DOI: 10.3389/fmed.2021.648005;
     
  9. Bosmann M. Complement control for COVID-19. Sci Immunol. 2021 05 25; 6(59). PMID: 34035117; PMCID: PMC8432947; DOI: 10.1126/sciimmunol.abj1014;
     
  10. Leister H, Luu M, Staudenraus D, Lopez Krol A, Mollenkopf HJ, Sharma A, Schmerer N, Schulte LN, Bertrams W, Schmeck B, Bosmann M, Steinhoff U, Visekruna A. Pro- and Antitumorigenic Capacity of Immunoproteasomes in Shaping the Tumor Microenvironment. Cancer Immunol Res. 2021 06; 9(6):682-692. PMID: 33707310; PMCID: PMC8355016; DOI: 10.1158/2326-6066.CIR-20-0492;
     
Showing 10 of 65 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 65 publications over 18 distinct years, with a maximum of 8 publications in 2020

YearPublications
20002
20011
20031
20051
20092
20101
20114
20127
20137
20144
20153
20161
20175
20183
20194
20208
20217
20224

2014 European Hematology Association: Clinical Research Fellowship
2013 Travel Grant
2013 55th ASH Annual Meeting: Abstract Achievement Award
2010 Travel Grant
2004 Allianz Health Insurance Corp: MD student travel award
Contact for Mentoring:
Bosmann's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department